Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Computational modeling and bioinformatic analyses of functional mutations in drug target genes in Mycobacterium tuberculosis
Pooja Singh, Salma Jamal, Faraz Ahmed, et al.
Computational and Structural Biotechnology Journal (2021) Vol. 19, pp. 2423-2446
Open Access | Times Cited: 15

Showing 15 citing articles:

A comprehensive review on genomics, systems biology and structural biology approaches for combating antimicrobial resistance in ESKAPE pathogens: computational tools and recent advancements
P. Priyamvada, Reetika Debroy, Anand Anbarasu, et al.
World Journal of Microbiology and Biotechnology (2022) Vol. 38, Iss. 9
Closed Access | Times Cited: 29
PIPENN-EMB ensemble net and protein embeddings generalise protein interface prediction beyond homology
David B. Thomas, C. Fernández, Reza Haydarlou, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Computational Design of Multitargeted Ligands to Counter Drug Resistance of Mycobacterium Tuberculosis
Varalakshmi Vummidi, Sekhar Talluri
The Open Medicinal Chemistry Journal (2025) Vol. 19, Iss. 1
Open Access
A comprehensive analysis of the mutational landscape of the newly emerging Omicron (B.1.1.529) variant and comparison of mutations with VOCs and VOIs
Chiranjib Chakraborty, Manojit Bhattacharya, Ashish Ranjan Sharma, et al.
GeroScience (2022) Vol. 44, Iss. 5, pp. 2393-2425
Open Access | Times Cited: 18
Deciphering Isoniazid Drug Resistance Mechanisms on Dimeric Mycobacterium tuberculosis KatG via Post-molecular Dynamics Analyses Including Combined Dynamic Residue Network Metrics
Victor Barozi, Thommas M. Musyoka, Olivier Sheik Amamuddy, et al.
ACS Omega (2022) Vol. 7, Iss. 15, pp. 13313-13332
Open Access | Times Cited: 14
Polypharmacological repurposing approach identifies approved drugs as potential inhibitors of Mycobacterium tuberculosis
Jasdeep Singh, Neha Quadir, Shubham Vashishtha, et al.
Biochemical Journal (2023) Vol. 480, Iss. 14, pp. 1079-1096
Open Access | Times Cited: 7
Genome and transcriptomic analysis of the adaptation of Escherichia coli to environmental stresses
Jianlu Jiao, Xiaoli Lv, Chongjie Shen, et al.
Computational and Structural Biotechnology Journal (2024) Vol. 23, pp. 2132-2140
Open Access | Times Cited: 2
Universal Lineage-Independent Markers of Multidrug Resistance in Mycobacterium tuberculosis
Hleliwe Hlanze, Awelani Mutshembele, Oleg N. Reva
Microorganisms (2024) Vol. 12, Iss. 7, pp. 1340-1340
Open Access | Times Cited: 1
Comparative genomic analysis of Escherichia coli strains obtained from continuous imipenem stress evolution
Juan Geng, Huiying Liu, Shuaiyin Chen, et al.
FEMS Microbiology Letters (2022) Vol. 369, Iss. 1
Closed Access | Times Cited: 6
An in silico evaluation of anthraquinone derivatives as potential inhibitors of DNA gyrase B of Mycobacterium tuberculosis
Juliana Carolina Amorim, Andrea E. Cabrera Bermeo, Viviana E. Vásquez Urgilés, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 4
Targeting of essential mycobacterial replication enzyme DnaG primase revealed Mitoxantrone and Vapreotide as novel mycobacterial growth inhibitors**
Waseem Ali, Salma Jamal, Rishabh Gangwar, et al.
Molecular Informatics (2023) Vol. 43, Iss. 3
Closed Access | Times Cited: 2
PIPENN-EMB: ensemble net and protein embeddings generalise protein interface prediction beyond homology
David B. Thomas, C. Fernández, Reza Haydarlou, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
A simplified pyrazinamidase test for Mycobacterium tuberculosis pyrazinamide antimicrobial susceptibility testing
Hsin-Hua Chan, Yuchen Wang, Ruwen Jou
Journal of Clinical Microbiology (2024)
Closed Access
Structure-based drug repurposing to inhibit the replication-associated essential protein DnaG of Mycobacterium tuberculosis.
Waseem Ali, Salma Jamal, Rishabh Gangwar, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 1
Clustering minimal inhibitory concentration data through Bayesian mixture models: An application to detect Mycobacterium tuberculosis resistance mutations
Clara Grazian
Statistical Methods in Medical Research (2023) Vol. 32, Iss. 12, pp. 2423-2439
Open Access
Page 1

Scroll to top